Table 1.
Treatment Group | Dosing (Day) | ||||
Pre-dose | 21 | 35 | 49 | 63 | |
| |||||
Control | 0.0 ± 0.0 | 0.4 ± 0.3 | 1.1 ± 0.4 | 1.3 ± 0.5 | 1.3 ± 0.4 |
ONO-5334 | 0.0 ± 0.0 | 0.1 ± 0.1 | 0.7 ± 0.2 | 0.6 ± 0.2 | 0.4 ± 0.2 |
MTX | 0.0 ± 0.0 | 0.1 ± 0.1 | 0.4 ± 0.3 | 0.4 ± 0.4 | 0.5 ± 0.5 |
ONO-5334/MTX | 0.0 ± 0.0 | 0.2 ± 0.1 | 0.7 ± 0.1 | 0.9 ± 0.4 | 0.7 ± 0.3 |
Data are presented as mean ± SE; control (n=8), ONO-5334 (n=9), methotrexate (n=8), and combination (n=9). The general condition of animals was evaluated in accordance with the following criteria: score 0: no abnormality; score 1: difficulty in hanging from the bars of the home cage by the fingers; score 2: inability to hang from the bars of the home cage by the fingers (using wrist); score 3: movement only by using forelimbs or hindlimbs; score 4: crouching.